Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis-Reference-Cited by-同舟云学术

Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis

Published:2024-01-23 Issue:2 Volume:102 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Antozzi Carlo¹^ORCID,Guptill Jeffrey¹^ORCID,Bril Vera¹,Gamez Josep¹^ORCID,Meuth Sven G.¹^ORCID,Nowak Richard J.¹^ORCID,Quan Dianna¹^ORCID,Sevilla Teresa¹^ORCID,Jouvin Marie-Helene¹^ORCID,Jin Jim¹,Karcher Keith¹,Ramchandren Sindhu¹^ORCID,Sun Hong¹,Ling Leona¹,Zhu Yaowei¹,Arroyo Santiago¹^ORCID,

Affiliation:

1. From the Neurological Institute Foundation C. Besta (C.A.), Milan, Italy; Duke University School of Medicine (J. Guptill), Durham, NC; Argenx US Inc. (J. Guptill), Boston, MA; University of Toronto (V.B.), ON, Canada; Universitat Autonoma de Barcelona, (J. Gamez), Spain; Medical Faculty (S.G.M.), Heinrich-Heine-University, Düsseldorf, Germany; Yale University School of Medicine (R.J.N.), New Haven, CT; University of Colorado School of Medicine (D.Q.), Aurora; Hospital Universitari i Politécnic La Fe...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000207937

Reference18 articles.

1. Myasthenia gravis: subgroup classification and therapeutic strategies

2. Antagonism of the Neonatal Fc Receptor as an Emerging Treatment for Myasthenia Gravis

3. Myasthenia gravis: Historical achievements and the “golden age” of clinical trials

4. International consensus guidance for management of myasthenia gravis

5. M281, an Anti‐FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First‐in‐Human Study

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Treatments for Myasthenia Gravis in Children and Adolescents;Pediatric Drugs;2024-08-28

2. Current Management of Warm Autoimmune Haemolytic Anaemia and Recent Advancements in Research: Interview with a Key Opinion Leader;EMJ Hematology;2024-08-14

3. Reimagining Myasthenia Gravis Care: Current Strategies and New Developments;EMJ Neurology;2024-08-13

4. Efficacy and Safety of Nipocalimab in Patients with Generalised Myasthenia Gravis: Top Line Results from the Double-Blind, Placebo-Controlled, Randomised Phase III Vivacity-MG3 Study;EMJ Neurology;2024-08-13

5. Inhibiting IgG in Hemolytic Disease of the Fetus;New England Journal of Medicine;2024-08-08